Shane Ward, Senior VP and General Counsel at BELLICUM PHARMACEUTICALS, INC (BLCM), bought 8,000 shares at $1.23 ($10K) on 2019-08-29, disclosed to the SEC on 2019-08-30.
Open-market purchase of $10k BLCM by Senior VP and General Counsel. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Several strong factors at once. The rarest rating we give.
| Filing → |
| CDTX | SELL | 2024-03-12 | $14K | — | Filing → |
| CDTX | SELL | 2023-03-13 | $7K | — | Filing → |
| VSAR | SELL | 2018-02-12 | $7K | — | Filing → |